Results 211 to 220 of about 146,774 (240)
Some of the next articles are maybe not open access.
D-004 EFFECTS OF AGING ON HUMAN CIRCULATORY SYSTEMS IN NORMALTENSIVE HEALTHY SUBJECTS
Journal of Hypertension, 2011Mike Lin +5 more
openaire +1 more source
P.6.d.004 Response to methadone maintenance treatment: what is the role of personality?
European Neuropsychopharmacology, 2014L. Galindo, F. Fonseca, M. Torrens
openaire +1 more source
P.7.d.004 Levetiracetam-induced psychiatric adverse events in children with epilepsy
European Neuropsychopharmacology, 2013N. Jovic, M. Belacevic
openaire +1 more source
P.7.d.004 Subacute sclerosing panencephalitis (SSPE): autistic behaviours treated with risperidone
European Neuropsychopharmacology, 2008T. Fidan, S. Algül, I. Kirpinar
openaire +1 more source
Drugs under experimental and clinical research, 2006
Benign prostatic hyperplasia (BPH) is a nonmalignant growth of prostate leading to difficulty in urinating. Drug therapy, phytotherapy included, is frequently used to treat BPH. D-004 is a lipid extract from Roystonea regia fruits, and previous studies have shown that oral treatment with D-004 for 14 days prevented prostate hyperplasia (PH) induced by ...
D, Carbajal +3 more
openaire +1 more source
Benign prostatic hyperplasia (BPH) is a nonmalignant growth of prostate leading to difficulty in urinating. Drug therapy, phytotherapy included, is frequently used to treat BPH. D-004 is a lipid extract from Roystonea regia fruits, and previous studies have shown that oral treatment with D-004 for 14 days prevented prostate hyperplasia (PH) induced by ...
D, Carbajal +3 more
openaire +1 more source
P.6.d.004 Regulation of the apoptotic machinery in the prefrontal cortex of human opioid abusers
European Neuropsychopharmacology, 2007J.A. García-Sevilla +5 more
openaire +1 more source
P.5.d.004 Psychiatric comorbidity in elderly patients with vascular cognitive disorder
European Neuropsychopharmacology, 2015openaire +1 more source